Ikarian Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.5M | Sell |
433,431
-90,000
| -17% | -$2.59M | 2.39% | 5 |
|
|
2025
Q1 | $17.6M | Buy |
523,431
+7,000
| +1% | +$235K | 2.16% | 2 |
|
|
2024
Q4 | $26.4M | Buy |
516,431
+89,518
| +21% | +$4.58M | 3.59% | 2 |
|
|
2024
Q3 | $21.8M | Sell |
426,913
-161,905
| -27% | -$8.27M | 3.04% | 2 |
|
|
2024
Q2 | $26.4M | Sell |
588,818
-54,933
| -9% | -$2.46M | 4.59% | 2 |
|
|
2024
Q1 | $30.1M | Sell |
643,751
-36,619
| -5% | -$1.71M | 3.3% | 1 |
|
|
2023
Q4 | $24.2M | Sell |
680,370
-112,550
| -14% | -$4M | 2.27% | 2 |
|
|
2023
Q3 | $23.6M | Buy |
792,920
+317,920
| +67% | +$9.45M | 2.84% | 2 |
|
|
2023
Q2 | $8.56M | Buy |
+475,000
| New | +$8.56M | 1.36% | 9 |
|
|
2020
Q4 | – | Sell |
-50,000
| Closed | -$784K | – | 155 |
|
|
2020
Q3 | $784K | Buy |
+50,000
| New | +$784K | 0.06% | 74 |
|